Spinal endothelin content is elevated after moderate local trauma in the rat to levels associated with locomotor dysfunction after intrathecal injection

Journal of Neurotrauma

Volumn 13, Issue 2, 1996, Pages 93-101

  Salzman, Steven K ^a,d   Acosta, Rafael ^b   Beck, George ^c   Madden, Justin ^a   Boxer, Barbara ^c   Ohlstein, Eliot H ^c  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

endothelin; locomotor deficits; rats; spinal cord injury

Indexed keywords

ENDOTHELIN; SYNTHETIC PEPTIDE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; LOCOMOTION; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PATHOPHYSIOLOGY; RAT; SPINAL CORD INJURY; TISSUE DISTRIBUTION; TISSUE INJURY;

EID: 0029944443     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.93     Document Type: Article

References (44)

1. ALAFACI, C., SALPIETRO, F.M., IOCOPING, D.G., EDVINSSON, L., and TOMASELLO, F. (1991). Endothelin: An endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm. Ital. J. Neurol. Sci. (Suppl. 2). Experimental Cerebral Ischemia, pp. 55-58.
2. ASANO, T., IKEGAKI, I., SATOH, S., SUZUKI, Y., SHIBUYA, M., SUGITA, K., and HIDAKA, H. (1990). Endothelin: A potential modulator of cerebral vasospasm. Eur. J. Phramacol. 19, 365-372.
3. BARONE, FC., GLOBUS, MY-T, PRICE, W.J., WHITE, R.F., STORER, B.L., FEUERSTEIN, G.Z., BUSTO, R., and OHLSTEIN, E.H. (1993). Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow Metab. 14, 331-342, 1994.
4. CHOI, D.W. (1988). Calcium-mediated relationship to specific channel types. A role in ischemic damage. Trends Neurosci. 11, 465-469.
5. CINTRA, A., FUXE, A.C.K., ANGGARD, E., TINNER, B., STAINES, W., and AGNATIC, L.F. (1989). Increased endothelin-like immunoreactivity in ibotenic acid-lesioned hippocampal formation of the rat brain. Acta Physiol. Scand. 137, 557-558.
6. CONN, P.I., SANDERS-BUSH, E., HUFFMAN, B.J., and HARTIG, P.R. (1986). A unique serotonin receptor in choroid plexus is linked to phosphotidylinositol turnover. Proc. Natl. Acad. Sci. U.S.A. 83, 4086-4088.
7. CONSTANTINI, S., and YOUNG, W. (1994). Ionic and water shifts in injured central nervous tissues. In: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds.), Oxford University Press, New York. pp. 123-130.
8. FADEN, A.I., and SALZMAN, S. (1992). Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29-35.
9. FADEN, A.I., and SIMON, R.P. (1988). A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23, 623-625.
10. FADEN, A.I., CHAN, P.M., and LONGAR, S. (1985). Alterations in lipid metabolism, Na, K, ATP-ase activity, and tissue water content of spinal cord following experimental traumatic injury. J. Neurochem. 48, 1809-1816.
11. FUJIMORI, A., YANAGISAWA, M., SAITO, A., GOTO, K., MASAKI, T., MIMA, T., and TAKAHURA, K. (1990). Endothelin in plasma and cerebrospinal fluid in patients with subarachnoid haemorrhage. Lancet 336, 633.
12. FURCHGOTT, R.F., and ZAWADZKI, U.V. (1986). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288, 373-376.
13. GARRIDO, M.R., and ISRAEL, A. (1994). Endothelin-3 stimulates phosphoinositide hydrolysis in the subfomical organ and median eminence of the rat brain. Brain Res. Bull. 33, 683-688.
14. GIAID, A., GIBSON, S.J., IBRAHIM, N.B.N., LEGON, S., BLOOM, S.R., YANAGISAWA, M., MASAKI, T., VARNDELL, I.M., and POLAK, J.M. (1989). Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 86, 7634-7638.
15. HOKFELT, T., POST, C., FREEDMAN, J., LUNDBERG, J.M., and TERENIUS, L. (1989). Endothelin induces spinal lesions after intrathecal administration. Acta Physiol. Scand. 137, 555-556.
16. HSU, C.Y., HALUSHKA, P.U., HAGEN, E.L., BANIK, N.C., LEE, W.A., and PEROT, P.L., JR. (1985). Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology 35, 1003-1009.
17. HSU, C.Y., HALUSHKA. P.U., and SPICER, K.M. (1988). Temporal profile of thromboxane-prostacyclin imbalance in experimental spinal cord injury. J. Neuroi. Sci. 85, 55-62.
18. HUNEIDI, A.H.S., THIEMERMANN, C., LIDBURY, P.S., DORLEANS-JUSTE, P., ANGGARD, E.E., AFSHAR, F., and VANE, J.R. (1991). Endothelin 1 and big endothelin cause subarachnoid hemorrhage in the anesthetized rabbit. J. Cardiovasc. Pharmacol. 17, S492-S495.
19. KOBAYASHI, H., HAYASHI, M., KOBAYASHI, S., KABUTO, M., HANDA, Y., and KAWANO, H. (1990). Effect of endothelin on the canine basilar artery. Neurosurgery 27, 357-361.
20. KOHLER, J., MAIR, P., WIESER, C., POMAROLI, A., PUSCHENDORF, B., and HEROLD, M. (1991). Endothelin and big endothelin concentrations in injured patients. N. Engl. J. Med. 325, 1518.
21. LEE, M-E., de la MONTE, S.M., NG, S-C., BLOCH, K.D., and QUERTERMOUS, T. (1990). Expression of the potent vasconstrictor endothelin in the human central nervous system. J. Clin. Invest. 86, 141-147.
22. MACCUMBER, M.W., ROSS, C.A., and SNYDER, H. (1990). Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. U.S.A. 87, 2359-2363.
23. McKENZIE, A.L., HALL, J.J., AIHARA, N., FUKUDA, K., and NOBLE, L.J. (1995). Immunolocalization of endothelin in the traumatized spinal cord: Relationship to blood-spinal cord barrier breakdown. J. Neurotrauma 12, 257-268.
24. MASAOKA, H., SUZUJI, R., HIRATA, Y., EMORI, T., MARUMA, F., and HIRAKAWA, K. (1989). Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2, 1402.
25. MATSUMOTO, H., SUZUKI, N., ONDA, H., and FUNINO, M. (1989). Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem. Biophys. Res. Common. 164, 74-80.
26. SALZMAN, S.K., HIROFUJI, E., LLADOS-ECKMAN, C., MACEWEN, G.D., and BECKMAN, A.L. (1987). Monoaminergic responses to spinal trauma: Participation of serotonin in posttraumatic progression of neural damage. J. Neurosurg. 66, 431-439.
27. SALZMAN, S.K., DABNEY, K.W., MENDEZ, A.A., BEAUCHAMP, J.T., DALEY, J.C., FREEMAN, G.M., FONSECA, A., INGERSOLL, E.B., BECKMAN, A.L., and BUNNELL, W.P. (1988). The somatosensory evoked potential predicts neurologic deficits and serotonergic pathochemistry after spinal distraction injury in experimental scoliosis. J. Neurotrauma 5, 173-186.
28. SALZMAN, S.K., KELLY, G., CHAVIN, J., WANG, L., PUNIAK, M.A., AGRESTA, C.A., and AZIM. S. (1994). Characterization of mianserin neuroprotection in experimental spinal trauma: Dose/route response and late treatment. J. Pharmacol. Exp. Ther. 269, 322-328.
29. SANDLER, A.N., and TATOR, C.H. (1976). Effect of acute spinal cord compression injury on regional spinal cord bloodflow in primates. J. Neurosurg. 45, 600-676.
30. SHIGENO, T., MIMA, T., TAKAKURA, K., YANAGISAWA, M., SAITO, A., GOTO, K., and MASAKI, T. (1989). Endothelin-1 acts in cerebral arteries from adventitial but not from the luminal side. J. Cardiovasc. Pharmacol. 13, S174-S176.
31. SHINIMI, O., KIMURA, S., SAWAMURA, T., SUGITA, Y., YOSHIZAWA, T., UCHIYAMA, Y., YANAGISAWA, M., GOTO, T., MASAKI, T., and KANAZAWA, I. (1989). Endothelin-3 is a novel neuropeptide: Isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem. Biophys. Res. Commun. 164, 587-593.
32. SHOHAMI, E., SHAPIRA, Y., YADID, G., REISFELD, N., and YEDGAR, S. (1989). Brain phospholipase A2 is actited after experimental closed head injury in the rat. J. Neurochem. 53, 1541-1546.
33. SUZUKI, H., SATO, S., SUZUJI, Y., TAKEKOSHI, K., ISHIHARA, N., and SHIMODA, S. (1990a). Increased endothelin concentration of CSF from patients with subarachnoid hemorrhage. Acta Neurol. Scand. 81, 553-554.
34. SUZUKI, H., SATA, S., SUZUJI, Y., OKA, M., TSUCHIYA, T., IINO, I., YAMANAKA, T., ISHIHARA, N., and SHIMODA, S. (1990b). Endothelin immunoreactiviry in cerebrospinal fluid in patients with subarachnoid haemorrhage. Animals Med. 22, 233-236.
35. SUZUKI, R., MASAOKA, H., HERAT, Y., MARUMO, F., ISOTANI, F., and KIRAKAWA, K. (1992). The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 77, 96-100.
36. TAKAHASHI, K., GHATEI, M., JONES, P.M., MURPHY, J.K., LAM, H-C., O'HALLORAN, D.J., and BLOOM, S.R. (1990). Endothelin in human brain and pituitary gland; presence of immunoreactive endothelin, endothelin mRNA and endothelin receptors. J. Clin. Endocrinol. Metab. 72, 693-699.
37. TAKAHASHI, H., NISHIMURA, M., NAKANISHI, T., HABUCHK, Y., TANAKA, H., IKEGAKI, I., and YOSHIMURA, M. (1991). Effects of intracerebro-ventricular and intravenous injections of endothelin-1 on blood pressure and sympathetic activity in urethane-anesthetized rats. J. Cardiovasc. Pharmacol. 17 Suppl. 7, S287-289.
38. TARLOV, I.M. (1957). Spinal Cord Compression: Mechanisms of Paralysis and Treatment. Charles C Thomas, Springfield, IL.
39. WILLETTE, R.N., and SAUERMELCH, C.F. (1990). Abluminal effect of endothelin in cerebral microvasculature assessed by laser-doppler flowmetry. Am. J. Physiol. 28, H1688-H1693.
40. WILLETTE, R.N., SAUERMELCH, C., EZEKIEL, M., FEUERSTEIN, G., and OHLSTEIN, E.H. (1990). Effect of endothelin on cortical microvascular perfusion in rats. Stroke 21, 451-458.
41. YAKSH, T.L., and RUDY, T.A. (1976). Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17, 1031-1036.
42. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M. MITSUI, Y., YAZAKI, Y., GOTO, K., and MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332, 411-415.
43. YOSHIMOTO, S., ISHIZAKI, Y., KURIHARA, H., SASAKI, T., YOSHIZUMI, M., YANAGISAWA, M., YAZAKI. Y., SAKI, T., TAKAKURA, K., and MUROTA, S. (1990). Cerebral microvessel endothelium is producing endothelin. Brain Res. 508, 283-285.
44. YUE, T-L., GLEASON, M.M., GU, J-L., LYSKO, P.G., HALLENBECK, J., and FEUERSTEIN G. (1991). Platelet activating factor (PAF) receptor mediated calcium mobilization and phosphinositide turnover in neurohybrid NG108-15 cells. Studies with BN50739. a new PAF antagonist. J. Pharmacol Exp. Ther. 257, 374-381.